BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 15682458)

  • 1. The fate of heterologous CD4+ T cells during Leishmania donovani infection.
    Polley R; Zubairi S; Kaye PM
    Eur J Immunol; 2005 Feb; 35(2):498-504. PubMed ID: 15682458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of protective T cells from BALB/cJ mice chronically infected with Leishmania donovani.
    Holaday B; Sadick MD; Pearson RD
    J Immunol; 1988 Sep; 141(6):2132-7. PubMed ID: 3262649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The phenotype and survival of antigen-stimulated transgenic CD4 T cells in vivo: the influence of persisting antigen.
    Yang CP; Sparshott SM; Duffy D; Garside P; Bell EB
    Int Immunol; 2006 Apr; 18(4):515-23. PubMed ID: 16481344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK; Naskar K; De T
    Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Leishmania donovani infection promotes bystander CD8+-T-cell expansion and heterologous immunity.
    Polley R; Sanos SL; Prickett S; Haque A; Kaye PM
    Infect Immun; 2005 Dec; 73(12):7996-8001. PubMed ID: 16299292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leishmania donovani infection of human myeloid dendritic cells leads to a Th1 response in CD4+ T cells from healthy donors and patients with kala-azar.
    Ghosh M; Mandal L; Maitra S; Rakshit S; Paul K; Bagchi J; Ganguly D; Pal C; Bandyopadhyay S
    J Infect Dis; 2006 Aug; 194(3):294-301. PubMed ID: 16826476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non PC liposome entrapped promastigote antigens elicit parasite specific CD8+ and CD4+ T-cell immune response and protect hamsters against visceral leishmaniasis.
    Sharma SK; Dube A; Nadeem A; Khan S; Saleem I; Garg R; Mohammad O
    Vaccine; 2006 Mar; 24(11):1800-10. PubMed ID: 16310900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen-specific accumulation of naïve, memory and effector CD4 T cells during anterior uveitis monitored by intravital microscopy.
    Dullforce PA; Seitz GW; Garman KL; Michael JA; Crespo SM; Fleischman RJ; Planck SR; Parker DC; Rosenbaum JT
    Cell Immunol; 2006 Jan; 239(1):49-60. PubMed ID: 16712823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visualizing memory phenotype development after in vitro stimulation of CD4(+) T cells.
    Lee WT; Pelletier WJ
    Cell Immunol; 1998 Aug; 188(1):1-11. PubMed ID: 9743552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells.
    Bertholet S; Debrabant A; Afrin F; Caler E; Mendez S; Tabbara KS; Belkaid Y; Sacks DL
    Infect Immun; 2005 Oct; 73(10):6620-8. PubMed ID: 16177338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics of CD62L/CD45RB CD4+ and CD8+ lymphocyte subsets in hepatic and splenic tissues during murine visceral leishmaniasis.
    Gomes-Pereira S; Rodrigues OR; Santos-Gomes GM
    Immunol Lett; 2004 Aug; 95(1):63-70. PubMed ID: 15325799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leishmania donovani vs immunity: T-cells sensitized from Leishmania of one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis.
    Narayan S; Bimal S; Singh SK; Gupta AK; Singh VP; Sinha PK; Das P
    Exp Parasitol; 2009 Jan; 121(1):69-75. PubMed ID: 18948098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice.
    Dey R; Majumder N; Bhattacharyya Majumdar S; Bhattacharjee S; Banerjee S; Roy S; Majumdar S
    Scand J Immunol; 2007 Dec; 66(6):671-83. PubMed ID: 18021365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LACK-reactive CD4+ T cells require autocrine IL-2 to mediate susceptibility to Leishmania major.
    Gumy A; Aseffa A; Rachinel N; Breton M; Otten L; Tacchini-Cottier F; Röcken M; Doyen N; Acha-Orbea H; Locksley RM; MacDonald HR; Launois P; Louis J
    Eur J Immunol; 2006 Jun; 36(6):1465-73. PubMed ID: 16637008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node cells from BALB/c mice with chronic visceral leishmaniasis exhibiting cellular anergy and apoptosis: involvement of Ser/Thr phosphatase.
    Mukherjee P; Sen PC; Ghose AC
    Apoptosis; 2006 Nov; 11(11):2013-29. PubMed ID: 17013755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmania donovani: role of CD2 on CD4+ T-cell function in Visceral Leishmaniasis.
    Bimal S; Singh SK; Sinha S; Pandey K; Sinha PK; Ranjan A; Bhattacharya SK; Das P
    Exp Parasitol; 2008 Feb; 118(2):238-46. PubMed ID: 17904553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+ T cell-independent maintenance and expansion of memory CD8+ T cells derived from in vitro dendritic cell activation.
    Shi M; Xiang J
    Int Immunol; 2006 Jun; 18(6):887-95. PubMed ID: 16621867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo activated OVA specific and non-specific CD4+CD25+ regulatory T cells exhibit comparable suppression to OVA mediated T cell responses.
    Li J; Bracht M; Shang X; Radewonuk J; Emmell E; Griswold DE; Li L
    Cell Immunol; 2006 Jun; 241(2):75-84. PubMed ID: 17010326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid receptor blockade increases the number of lymphocytes without altering T cell response in draining lymph nodes in vivo.
    Jaume M; Laffont S; Chapey E; Blanpied C; Dietrich G
    J Neuroimmunol; 2007 Aug; 188(1-2):95-102. PubMed ID: 17617474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis.
    Oliveira-Freitas E; Casas CP; Borja-Cabrera GP; Santos FN; Nico D; Souza LO; Tinoco LW; da Silva BP; Palatnik M; Parente JP; Palatnik-de-Sousa CB
    Vaccine; 2006 May; 24(18):3909-20. PubMed ID: 16556475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.